{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:48:09Z","timestamp":1791978489205,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1788-7","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T07:41:51Z","timestamp":1537774911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Novel in-frame deletion in MFSD8 gene revealed by trio whole exome sequencing in an Iranian affected with neuronal ceroid lipofuscinosis type 7: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Ali","family":"Hosseini Bereshneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Garshasbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"1788_CR1","unstructured":"Geraets RD, Koh SY, Hastings ML, Kielian T, Pearce DA, Weimer JM. Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis. Orphanet J. Rare Dis. 2016;11(1):40."},{"issue":"3","key":"1788_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ddrr.1118","volume":"17","author":"MJ Bennett","year":"2013","unstructured":"Bennett MJ, Rakheja D. The neuronal ceroid-lipofuscinoses. Dev. Disabil. Res. Rev. 2013;17(3):254\u20139.","journal-title":"Dev. Disabil. Res. Rev"},{"issue":"1","key":"1788_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2013.08.008","volume":"50","author":"RH Jadav","year":"2014","unstructured":"Jadav RH, Sinha S, Yasha TC, Aravinda H, Gayathri N, Rao S, Bindu PS, Satishchandra P. Clinical, electrophysiological, imaging, and ultrastructural description in 68 patients with neuronal ceroid lipofuscinoses and its subtypes. Pediatr Neurol. 2014;50(1):85\u201395.","journal-title":"Pediatr Neurol"},{"issue":"01","key":"1788_CR4","first-page":"047","volume":"5","author":"D Albert","year":"2016","unstructured":"Albert D, De Los RE, Vidaurre J. A case of neuronal Ceroid Lipofuscinosis masquerading as Panayiotopoulos syndrome. J Pediatr Epilepsy. 2016;5(01):047\u201352.","journal-title":"J Pediatr Epilepsy"},{"issue":"1","key":"1788_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10048-008-0153-1","volume":"10","author":"E Stogmann","year":"2009","unstructured":"Stogmann E, El Tawil S, Wagenstaller J, Gaber A, Edris S, Abdelhady A, Assem-Hilger E, Leutmezer F, Bonelli S, Baumgartner C, Zimprich F. A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis. Neurogenetics. 2009;10(1):73\u20137.","journal-title":"Neurogenetics"},{"key":"1788_CR6","first-page":"088307381349426","volume":"9","author":"JW Mink","year":"2013","unstructured":"Mink JW, Augustine EF, Adams HR, Marshall FJ, Kwon JM. Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol. 2013;9:0883073813494268.","journal-title":"J Child Neurol"},{"issue":"11","key":"1788_CR7","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","volume":"1832","author":"M Haltia","year":"2013","unstructured":"Haltia M, Goebel HH. The neuronal ceroid-lipofuscinoses: a historical introduction. Biochim Biophys Acta. 2013;1832(11):1795\u2013800.","journal-title":"Biochim Biophys Acta"},{"key":"1788_CR8","volume-title":"The neuronal ceroid lipofuscinoses (Batten disease)","author":"HH Goebel","year":"1999","unstructured":"Goebel HH, Mole SE, Lake BD. The neuronal ceroid lipofuscinoses (Batten disease). Amsterdam: IOS Press; 1999."},{"key":"1788_CR9","unstructured":"NCL mutation database. Available at: https:\/\/www.ucl.ac.uk\/ncl\/SummaryTableMay2015.htm ."},{"issue":"11","key":"1788_CR10","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","volume":"1832","author":"V Warrier","year":"2013","unstructured":"Warrier V, Vieira M, Mole SE. Genetic basis and phenotypic correlations of the neuronal ceroid lipofuscinoses. Biochim Biophys Acta. 2013;1832(11):1827\u201330.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1788_CR11","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1086\/302427","volume":"64","author":"DE Sleat","year":"1999","unstructured":"Sleat DE, Gin RM, Sohar I, Wisniewski K, Sklower-Brooks S, Pullarkat RK, Palmer DN, Lerner TJ, Boustany RM, Uldall P, Siakotos AN. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am J Hum Genet. 1999;64(6):1511\u201323.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1788_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","volume":"6","author":"SE Mole","year":"2005","unstructured":"Mole SE, Williams RE, Goebel HH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics. 2005;6(3):107\u201326.","journal-title":"Neurogenetics"},{"issue":"4","key":"1788_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","volume":"1793","author":"A Jalanko","year":"2009","unstructured":"Jalanko A, Braulke T. Neuronal ceroid lipofuscinoses. Biochim Biophys Acta. 2009;1793(4):697\u2013709.","journal-title":"Biochim Biophys Acta"},{"issue":"5333","key":"1788_CR14","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","volume":"277","author":"DE Sleat","year":"1997","unstructured":"Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK, Lobel P. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science. 1997;277(5333):1802\u20135.","journal-title":"Science"},{"issue":"s2","key":"1788_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1684\/epd.2016.0844","volume":"18","author":"DA Nita","year":"2016","unstructured":"Nita DA, Mole SE, Minassian BA. Neuronal ceroid lipofuscinoses. Epileptic Disord. 2016;18(s2):73\u201388.","journal-title":"Epileptic Disord"},{"issue":"6","key":"1788_CR16","first-page":"845","volume":"127","author":"JK G\u00f6tzl","year":"2014","unstructured":"G\u00f6tzl JK, Mori K, Damme M, Fellerer K, Tahirovic S, Kleinberger G, Janssens J, van der Zee J, Lang CM, Kremmer E, Martin JJ. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis. Acta Neuropathol. 2014;127(6):845\u201360.","journal-title":"Acta Neuropathol"},{"key":"1788_CR17","first-page":"S11","volume":"114","author":"A Karaa","year":"2015","unstructured":"Karaa A, Simas AM, John S, Glykys J, Xin W, Cotman SL, Sims KB. Expanding the clinical spectrum of the lysosomal disorders with whole exome sequencing. Abstracts\/Mol. Genet. Metab. 2015;114:S11\u201330.","journal-title":"Abstracts\/Mol. Genet. Metab"},{"issue":"10","key":"1788_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s12098-015-1979-9","volume":"83","author":"J Patel","year":"2016","unstructured":"Patel J, Mercimek-Mahmutoglu S. Epileptic encephalopathy in childhood: a stepwise approach for identification of underlying genetic causes. Indian J. Pediatr. 2016;83(10):1164\u201374.","journal-title":"Indian J. Pediatr"},{"key":"1788_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-3-662-49410-3_27","volume-title":"Inherited metabolic diseases: A clinical approach","author":"A Garc\u00eda-Cazorla","year":"2017","unstructured":"Garc\u00eda-Cazorla A, Wolf NI, Mochel F, Hoffmann GF. Neurological disease. In: Hoffman GF, Zschocke J, Nyhan WL, editors. Inherited metabolic diseases: A clinical approach. Berlin Heidelberg: Springer; 2017. p. 251\u201392."},{"key":"1788_CR20","first-page":"1","volume-title":"Stem cell therapy in Lysosomal storage diseases","author":"EJ Langereis","year":"2013","unstructured":"Langereis EJ, Wijburg FA. Lysosomal diseases and therapeutic options: an overview. In: Boelens JJ, Wynn R, editors. Stem cell therapy in Lysosomal storage diseases. New York: Springer; 2013. p. 1\u201320."},{"key":"1788_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/9781118514672.ch18","volume-title":"Lysosomal Storage Disorders: A Practical Guide","author":"JD Cooper","year":"2012","unstructured":"Cooper JD, Williams RE. Neuronal Ceroid Lipofuscinoses. In: Mehta A, Winchester B, editors. Lysosomal Storage Disorders: A Practical Guide, vol. 4; 2012. p. 137\u201341."},{"issue":"1","key":"1788_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0888-7543(91)90235-7","volume":"9","author":"I J\u00e4rvel\u00e4","year":"1991","unstructured":"J\u00e4rvel\u00e4 I, Schleutker J, Haataja L, Santavuori P, Puhakka L, Manninen T, Palotie A, Sandkuijl LA, Renlund M, White R, Aula P. Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics. 1991;9(1):170\u20133.","journal-title":"Genomics"},{"issue":"01","key":"1788_CR23","doi-asserted-by":"publisher","first-page":"060","DOI":"10.1055\/s-0036-1582222","volume":"6","author":"M Grisolia","year":"2016","unstructured":"Grisolia M, Sestito S, Ceravolo F, Invernizzi F, Salpietro V, Polizzi A, Ruggieri M, Garavaglia B, Concolino D. The neuronal Ceroid Lipofuscinoses: a case-based overview. J Pediatr Biochemistry. 2016;6(01):060\u20135.","journal-title":"J Pediatr Biochemistry"},{"key":"1788_CR24","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/brain\/awt043","volume":"136","author":"F Mahmood","year":"2013","unstructured":"Mahmood F, Fu S, Cooke J, Wilson SW, Cooper JD, Russell C. A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferation. Brain. 2013;136:1488\u2013507.","journal-title":"Brain"},{"key":"1788_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.dib.2016.06.027","volume":"8","author":"HM Minye","year":"2016","unstructured":"Minye HM, Fabritius AL, Vesa J, Peltonen L. Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin. Data in Brief. 2016;8:741\u20139.","journal-title":"Data in Brief"},{"key":"1788_CR26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/978-1-84882-128-6_182","volume-title":"Atlas of epilepsies","author":"SE Mole","year":"2010","unstructured":"Mole SE, Goyal S, Williams RE. The neuronal Ceroid Lipofuscinoses. In: Panayiotopoulos CP, editor. Atlas of epilepsies. London: Springer; 2010. p. 1235\u201341."},{"key":"1788_CR27","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.1093\/hmg\/ddu316","volume":"23","author":"SS Kashyap","year":"2014","unstructured":"Kashyap SS, Johnson JR, McCue HV, Chen X, Edmonds MJ, Ayala M, Graham ME, Jenn RC, Barclay JW, Burgoyne RD, Morgan A. Caenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for neuroprotective drug screening and identifies a SIR-2.1-independent action of resveratrol. Human Molecular Genetics. 2014;23:5916\u201327.","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"1788_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejpn.2014.07.008","volume":"19","author":"D Craiu","year":"2015","unstructured":"Craiu D, Dragostin O, Dica A, Hoffman-Zacharska D, Gos M, Bastian AE, Gherghiceanu M, Rolfs A, Nahavandi N, Craiu M, Iliescu C. Rett-like onset in late-infantile neuronal ceroid lipofuscinosis (CLN7) caused by compound heterozygous mutation in the MFSD8 gene and review of the literature data on clinical onset signs. Eur J Paediatr Neurol. 2015;19(1):78\u201386.","journal-title":"Eur J Paediatr Neurol"},{"key":"1788_CR29","doi-asserted-by":"publisher","first-page":"W529","DOI":"10.1093\/nar\/gkq399","volume":"38","author":"H Ashkenazy","year":"2010","unstructured":"Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N. ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res. 2010;38:W529\u201333.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1788_CR30","doi-asserted-by":"publisher","first-page":"E530","DOI":"10.1002\/humu.20975","volume":"30","author":"C Aiello","year":"2009","unstructured":"Aiello C, Terracciano A, Simonati A, Discepoli G, Cannelli N, Claps D, Crow YJ, Bianchi M, Kitzmuller C, Longo D, Tavoni A. Mutations in MFSD8\/CLN7 are a frequent cause of variant-late infantile neuronal ceroid lipofuscinosis. Hum Mutat. 2009;30(3):E530\u201340.","journal-title":"Hum Mutat"},{"issue":"1","key":"1788_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/(SICI)1096-8628(19970221)74:1<73::AID-AJMG16>3.0.CO;2-O","volume":"74","author":"MT Abrams","year":"1997","unstructured":"Abrams MT, Doheny KF, Mazzocco MM, Knight SJ, Baumgardner TL, Freund LS, Davies KE, Reiss AL. Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE. Am J Med Genet. 1997;74(1):73\u201381.","journal-title":"Am J Med Genet"},{"key":"1788_CR32","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1093\/nar\/gkn1058","volume":"37","author":"M Bensaid","year":"2009","unstructured":"Bensaid M, Melko M, Bechara EG, Davidovic L, Berretta A, Catania MV, Gecz J, Lalli E, Bardoni B. FRAXE-associated mental retardation protein (FMR2) is an RNA-binding protein with high affinity for G-quartet RNA forming structure. Nucleic Acids Research. 2009;37:1269\u201379.","journal-title":"Nucleic Acids Research"},{"issue":"19","key":"1788_CR33","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1093\/hmg\/dds267","volume":"21","author":"K Mondal","year":"2012","unstructured":"Mondal K, Ramachandran D, Patel VC, Hagen KR, Bose P, Cutler DJ, Zwick ME. Excess variants in AFF2 detected by massively parallel sequencing of males with autism spectrum disorder. Hum Mol Genet. 2012;21(19):4356\u201364.","journal-title":"Hum Mol Genet"},{"key":"1788_CR34","series-title":"United States patent application US 12\/842,678","volume-title":"Genomic editing of genes involved in autism spectrum disorders","author":"E Weinstein","year":"2010","unstructured":"Weinstein E, Cui X, Simmons P, Sigma-Aldrich Co. Genomic editing of genes involved in autism spectrum disorders. United States patent application US 12\/842,678. 2010."},{"issue":"3","key":"1788_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/cge.12148","volume":"85","author":"A Todorova","year":"2014","unstructured":"Todorova A, Litvinenko I, Todorov T, Tincheva R, Avdjieva D, Tincheva S, Mitev V. A family with fragile X syndrome, Duchenne muscular dystrophy and ichthyosis transmitted by an asymptomatic carrier. Clin Genet. 2014;85(3):286\u20139.","journal-title":"Clin Genet"},{"issue":"12","key":"1788_CR36","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1002\/ajmg.a.34345","volume":"155","author":"T Sahoo","year":"2011","unstructured":"Sahoo T, Theisen A, Marble M, Tervo R, Rosenfeld JA, Torchia BS, Shaffer LG. Microdeletion of Xq28 involving the AFF2 (FMR2) gene in two unrelated males with developmental delay. Am J Med Genet A. 2011;155(12):3110\u20135.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"1788_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/humu.1165","volume":"18","author":"CB Santos","year":"2001","unstructured":"Santos CB, Lima C, Pimentel MM. A new PCR assay useful for screening of FRAXE\/FMR2 mental impairment among males. Hum Mutat. 2001;18(2):157\u201362.","journal-title":"Hum Mutat"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1788-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T20:55:16Z","timestamp":1605041716000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1788-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1788"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1788-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"2 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The involved family was informed about the benefits and consequence of genetics testing and a written consent letter was also obtained for their participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian(s) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"281"}}